Recent methods in DNA nanotechnology are enabling the creation of intricate nanostructures through the use of programmable, bottom-up self-assembly. However, structures consisting only of DNA are limited in their ability to act on other biomolecules. Proteins, on the other hand, perform a variety of functions on biological materials, but directed control of the self-assembly process remains a challenge. While DNAprotein hybrids have the potential to provide the best-of-both-worlds, they can be difficult to create as many of the conventional techniques for linking proteins to DNA render proteins dysfunctional. We present here a sortase-based protocol for covalently coupling proteins to DNA with minimal disturbance to protein function. To accomplish this we have developed a two-step process. First, a small synthetic peptide is bioorthogonally and covalently coupled to a DNA oligo using click chemistry. Next, the DNA-peptide chimera is covalently linked to a protein of interest under protein-compatible conditions using the enzyme sortase. Our protocol allows for the simple coupling and purification of a functional DNA-protein hybrid. We use this technique to form oligos bearing cadherin-23 and protocadherin-15 protein fragments. Upon incorporation into a linear M13 scaffold, these protein-DNA hybrids serve as the gate to a binary nanoswitch. The outlined protocol is reliable and modular, facilitating the construction of libraries of oligos and proteins that can be combined to form functional DNA-protein nanostructures. These structures will enable a new class of functional nanostructures, which could be used for therapeutic and industrial processes. Ó 2014 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
DNA is emerging as the platform of choice for the bottom-up self-assembly of intricate, biocompatible nanostructures. As techniques for the programmed patterning of these structures have advanced, it is now possible to create complex assemblies, ranging from two dimensional shapes to three-dimensional nano-robots [1] [2] [3] . Structures built using only DNA, although intricate, are limited in their ability to interact with biological substrates. Proteins, on the other hand, are the molecular machines of biology, and have a wide range of functions including chemically modifying, binding to, and applying forces to other molecules. However, to build intricate machines using DNA-protein hybrids, which harness the advantages of both materials, one needs to attach the proteins in a targetable and biocompatible way [4, 5] .
One approach is to attach the proteins to the oligonucleotides (oligos) that bind to designated locations on the DNA origami scaffold. The challenge, however, is to attach these proteins to oligos while preserving protein function. Existing chemistries, such as disulfide and SMCC (sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate) linkage [6] , are sometimes effective, but they react with functional groups ubiquitous in biology. This reactivity hinders both the ability to link to a desired location on the protein, and to control the number of linkers bound to each molecule (stoichiometry), as one biomolecule may contain many reactive species. To overcome this issue, bioorthogonal techniques, such as copper-free click-chemistry, have been developed [7] . Although these techniques do in fact overcome the issues of regioselectivity and stoichiometry, they still suffer from the problem common to all of these techniques: reaction conditions are suboptimal for many proteins, be it due to long incubation periods at room temperature, extreme oxidizing/reducing conditions, or non-physiological pH. These methods also fail when working with non-thermostable proteins that have a tendency to aggregate and/ or precipitate out of solution under the requisite conditions. Additionally, purification can be difficult due to the challenge of easily distinguishing products from reactants-as we will see, our technique solves this problem by directly marking successful reactions by the simultaneous removal of an affinity label. Finally, each protein has specific considerations with regards to its reactivity and structural stability. Thus protocols optimized for one protein may not be suitable for another protein.
Here, we present a protocol for covalent coupling developed to meet the challenges outlined above. In order to preserve protein function, protein-DNA coupling is performed under physiological conditions. In this two-step process, a small synthetic peptide is first coupled to a DNA oligo. Next, utilizing the enzyme sortase [8, 9] , the protein is coupled to the DNA-peptide chimera under physiological conditions. This strategy frontloads all of the protein-incompatible chemistry so that it is performed on an oligo and a synthetic peptide, which are far more tolerant of non-physiological conditions. The use of sortase also facilitates purification, as coupling of the oligo is accompanied by the removal of an affinity tag. Our protocol, detailed below, allows for the use of commercially available purification resins to yield the product of interest free of any side products and reactants. This technique can be used to generate libraries of oligo nucleotides and proteins such that any proteins in the library can be easily and reliably attached anywhere along the DNA origami scaffold.
To demonstrate the utility of this technique we build the simplest DNA-protein nanomachine, a binary DNA-nanoswitch [6] , gated by the interacting pair of cadherin-23 and protocadherin-15 protein fragments (CDH23 and PCDH15) [10, 11] . This self-assembled mechanical switch changes state to report the formation or rupture of biomolecular bonds: in this case, the switch is closed when CDH23 is bound to PCDH15 and open otherwise. The CDH23 fragment is covalently linked to an oligo that hybridizes one-third of the way in from one edge of the DNA scaffold (M13). In addition, the PCDH15 fragment is linked to an oligo that hybridizes one-third of the way in from the other edge of the scaffold (Fig. 1) . The result is a nanoswitch with an end-to-end length of 3 lm when the proteins are not interacting, and an end-to-end length of 2 lm when the proteins are interacting. These two states are resolvable via gel electrophoresis as described in [6] . In vivo some variants of sortase, such as sortase-A are used to anchor proteins to the cell surface by covalently linking proteins to the peptidoglycan on the cell walls of bacteria. In this in vitro system sortase covalently links the N-terminus of one protein to a location near (within 100 amino acids of) the C-terminus of another protein.
Sortase recognizes an N-terminal GGG and a C-terminal LPX 1 TGX 2 , where X 1 can be any amino acid, and X 2 can be any string of amino acids of length 1-99. Sortase then facilitates the transposition of the glycine residues in the two proteins resulting in a covalent linkage between the two proteins and the release of GX 2 (Fig. 2) .
Maximillian Popp et al. in 2007 [9] first described using sortase to selectively attach fluorescent markers to a protein of interest. Chen et al. in 2011 [8] evolved a sortase variant with 140-fold increased activity, lowering coupling times from hours to minutes. Sortase has also been used to link peptide nucleic acids (PNA) to peptides [12] , to label proteins N-terminally [13] , C-terminally, and in loops [14] . Additionally sortase has been used in combination with click chemistry to make unnatural N-N-and C-C-linked protein chimeras [15] .
Our goal was to use sortase technology to generate DNAprotein hybrids for self-assembled nanostructures. While synthetic PNA oligos offer the ability to append amino acids directly to a string of nucleic acids, they are less soluble than DNA oligos, and harder to synthesize. Thus, we wanted instead to develop a convenient way to couple proteins to DNA oligos which are more readilyavailable. To do this we needed a means of attaching a peptide to an oligo. Click chemistry was chosen to allow for the process to be both bioorthogonal and efficient.
Methods
Here we present four protocols describing: (2.1) the formation of a DNA-oligo bearing a sortase-compatible GGG-peptide, (2.2) In the paper we also outline a method for attaching thermo-stable proteins to a DNA origami scaffold. For thermo-stable proteins, one can perform the sortasebased coupling reactions on the individual oligos separately prior to thermally annealing the oligos to the M13 scaffold, thus obviating the need for the protecting Flag-tag (2.3).
the sortase-catalyzed coupling of a protein to the DNA-peptide chimera, and (2.3/2.4) the integration of DNA-protein hybrids into self-assembling nanostructures for thermostable/non-thermostable proteins. The oligos we were interested in functionalizing for our application were both 60 bp oligos herein referred to as oligo 1 and oligo 2. We ordered oligo 1 with a 3 0 -azide and oligo 2 was ordered with a 5 0 -azide (IDT custom oligo). The following peptide was synthesized by NeoBioLab: (N->C) Flag-TEV-GGG-Pra (DYKDDDDK-ENLYFQ-GGG-Pra) where Pra is the unnatural amino acid propargylglycine. This can be incorporated into a synthetic peptide to provide an alkyne, the complimentary click reagent. Additionally, to facilitate purification, a Flag-tag was added to the N-terminus. As the sortase requires the GGG to be on a free N-terminus, a tobacco etch virus cleavage site (TEV) was inserted to allow for removal of the Flag-tag. 2.1.2. Click-coupling of the peptide to the oligo (Fig. 3) a. Combine the following in a 250 lL DNA-lowbind tube: 35 lL of the azide-oligo, 30 lL of the peptide, 12 lL of the ascorbic acid, and 8.5 lL of CuSO 4 . Note: CO 2 (g) is produced from the ammonium bicarbonate. Also, although the peptide is insoluble at neutral pH, it is soluble under both the slightly basic ammonium bicarbonate conditions and the acidic ascorbic acid conditions. b. Allow the reaction to sit for 2 h at room temperature to ensure completion. c. Note: some of the Cu will be reduced to Cu(0) metal, which will precipitate out. (Fig. 4) . Method 1: Neutralization 1. Neutralizing the solution via the addition of 250 lL of TBS (50 mM TrisHCl pH 7.6, 300 mM NaCl) will cause uncoupled peptide to precipitate. 2. The copper metal and precipitated peptide can be pelleted by centrifugation at 16,000g for 5 min. The supernatant will contain coupled and uncoupled oligo and excess Cu(I) can be dialyzed out using a 6-8 kDa membrane (Mini GeBAflex-tube, T070-6).
Method 2: QiaQuick nucleotide removal kit (Qiagen) (The Qiagen kit works by precipitating out DNA, passing it over a membrane, and washing away any soluble products such as unconjugated peptides, small molecules, soluble copper etc.).
1. Following the kit protocol will remove the copper metal, Cu(I), Cu(II), and the uncoupled peptide. 2. The protocol should be followed as instructed by the manufacturer, but the wash step should be repeated a second time.
3. Perform the elution with 200 lL of TBS. (Fig. 5) a. Wash 1 ml of Anti-Flag M2 magnetic beads (Sigma-Aldrich, M8823) three times with 1 ml of TBS. b. Apply the product of the Qiagen purification column and allow to bind for 1-2h rotating at room temperature.
Removal of uncoupled oligo
c. Wash the beads at least 4 times with 500 ll of TBS being sure to agitate the beads to remove any uncoupled oligo. Note: A wide boar pipette is recommended when agitating the beads. d. Elute with 1 ml of 0.1 mg/ml (Sigma) Flag peptide in eTBS (50 mM TrisHCl pH 7.6, 150 mM NaCl). Allow 1 h rotating at room temperature for elution. e. A second elution can be performed, but >85% will be recovered in the first elution. (Fig. 6) a. Add 2 lL of 2 mg/ml TEV protease (Sigma-Aldrich, T4455) to each ml of eluted product. b. Incubate in a 30 o C water bath over night.
TEV-cleavage of the Flag-tag
c. Running a 4-20% gradient poly-acrylamide gel with the binding, wash, and elution (cleaved and uncleaved) supernatants reveals that the product has been successfully purified of uncoupled oligo (The 60 bp band is eliminated with successive washes) and cleaved (after cleavage the band shifts back near 60 bp).
The final product will herein be referred to as GGG-oligo. Additionally the TEV and cleaved peptide can be removed by repeating the Qiagen nucleotide removal kit as described above. This step, however, has not proven to be necessary.
Protocol for sortase coupling LPETG-tagged proteins to GGGoligonucleotides 2.2.1. Preparation of reagents
a. The GGG-oligo should be at a concentration of 2 lM as judged by band intensity on the polyacrylamide gel. The gel was stained with SYBR-Gold (Invitrogen, S11494), imaged using a GE Typhoon FLA-9500, and analyzed using ImageJ (NIH, 1.46r). b. Two proteins, protein1 and 2, are coupled to two different oligos, oligo1 and 2. In this example protein 1 is a fragment of the CDH23 protein containing two (out of 27) extracellular repeats. Likewise, protein 2 is a PCDH15 fragment containing two (out of 11) extracellular repeats. Both proteins were modified by appending the LPETG amino-acid sequence between the protein fragment C-terminus and a His-tag. Protein fragments were produced as described in [11, 16] . c. Proteins should be used at a minimum concentration of 0.1 mM. CDH23-LPETG and PCDH15-LPETG stocks were at 2.5 and 2.7 mg/ml respectively in TBS + 5 mM CaCl 2 (0.1 mM). CDH23-LPETG and PCDH15-LPETG were fragments, each containing two extracellular domains used in a crystallographic study [11] . The proteins were modified by appending LPETG between the His-tag and the C-terminus of the protein. d. Sortase stock was at 1.5 mg/ml in TBS + 10%-glycerol. An evolved variant of sortase-A from Staphylococcus aureus [8] was expressed and purified from Escherichia coli (plasmids and expression protocol provided by Brent Dorr in David Liu's lab [8] ). e. Sortase Reaction buffer consisted of the following: 300 mM TrisHCl pH 7.5, 5 mM MgCl 2, 5 mM CaCl 2 , and 150 mM NaCl. Fig. 4 . Removal of Cu and uncoupled peptide. Running the reaction product through a Qiagen nucleotide removal kit allows for the isolation of the coupled and uncoupled oligo. Excess peptide and copper will remain on the membrane and/or be removed in the wash steps. (Fig. 7) a. Mix the following in a 250 lL mini GEBAflex-tube: 140 lL of 2 lM GGG-oligo1, 40 lL of 0.1 mM protein1-LPETG-HHHHHH, 5 lL of sortase, 65 lL of sortase reaction Buffer.
Sortase coupling of protein1 to oligo1
Note: The protein is added in large excess to drive coupling to completion with respect to the oligo. Place the GEBAflex tube in 1L of sortase reaction buffer and allow the reaction to go for 1hr at RT or 4-5 h at 4°C. The dialysis column will allow any Flag peptide to dialyze out and will remove the sortase reaction byproduct, G-HHHHHH, which can compete with the oligo. b. Fig. 8 shows SDS-PAGE analysis indicating that the protein oligo chimera is only formed when all components are present. (Fig. 9) a. The TEV, sortase, protein 1, and protein 2 all bear His tags. The sortase reaction, however, selectively cleaves the His tag off of the final product. Thus passing the product over anti-His magnetic beads will remove these reactants leaving the final product in the supernatant. Note: anti-His beads should be used rather than Ni-NTA. The Ni-NTA beads tend to bind the oligos quite strongly and very high salt is required to remove them. PBS can be used for these washes and for those in step c. This is to remove any phosphate from the storage solution to prevent calcium-phosphate crystal formation. Omitting this step will result in large losses in later steps. c. Wash 3 more times with 1 ml of TBS + 5 mM CaCl 2 . d. Apply the product of the sortase reaction and allow 2 h rotating at 4°C for binding. e. The supernatant contains the DNA-protein hybrid, free of any other proteins. In our molecular system we obtain a yield of 65% with respect to the amount of starting oligo.
Purification of protein-oligo chimera

Protocol for hybridization of DNA-protein hybrid to scaffold (thermostable proteins)
If the protein used can withstand being heated to 40 o C, the oligos can be hybridized to the scaffold, in this case linearized M13 [6] , by adding the oligos in a one-to-one ratio to the scaffold, then ramping the temperature from 40°C to 20°C at half a degree per minute in a thermocycler [6] . One can anneal all unfunctionalized oligos from 95°C in 0.5 degree steps to 20°C. The functionalized oligos can be added during this run by pausing the thermocycler once it hits 40°C, adding the functionalized oligos. If the protein is not thermostable an alternate approach can be taken as described below in Section 2.4.
Protocol for hybridization of DNA-protein hybrid to scaffold (nonthermostable proteins)
In this example the CDH23 and PCDH15 fragments are not very thermostable and hybridization through temperature annealing was not an option. For this system the GGG-oligos were hybridized onto the scaffold and the sortase coupling was done in situ directly on the scaffold. Performing the coupling on the oligos before hybridization allows one to easily control which protein is attached to which oligo. For this system selective coupling was achieved using the Flag-tag as a protecting group. That is, oligo 1 was processed fully, resulting in a GGG-oligo, while oligo 2 did not undergo TEV cleavage of its Flag tag (Fig. 1 ).
An additional concern is ensuring that each site on the scaffold receives its complimentary oligo. To accomplish this, the oligos are added at 50-fold excess. This, however, results in a large surplus of free floating oligos. This can be a problem if there is an excess of GGG-oligo floating around which will compete with the in situ reaction. To overcome this issue excess oligos had to be removed from the solution.
Preparation of reagents
a. The GGG-and Flag-TEV-GGG-oligos should be concentrated to 10 lM. This can be achieved by using a speedvac (Thermo-Savant, SC210A) or a 3 kDa spin column (Vivaspin 500, VS0191). Note: If a speedvac is used the oligos should first be dialyzed into water to remove salts before concentration. . Sortase-catalyzed production of protein-DNA hybrids. An LPETG-containing protein, in this case CDH23 EC1 + 2, is coupled to the Gly-Gly-Gly-oligo via sortase. Sortase transposes the two glycine residues highlighted by the red box, resulting in the formation of a peptide bond between the protein and the Gly-Gly-Gly-oligo (we note that the recognition sequences do not first align, but rather, sortase binds to the LPX 1 TGX 2 sequence first, as described in Fig. 2(B) ). In this case the sequence after the Cterminal-most glycine on the protein was a 6xHis-tag. Sortase cleaves and releases this affinity tag, replacing it with the Gly-Gly-Gly-oligo. The procedure is carried out in a dialysis membrane so the Flag-TEV and G-His-tag peptides are dialyzed out. e. Add 4 lL of 2 mg/ml TEV and allow to sit at room temperature for 1 h. f. If your protein buffer contains Ca 2+ wash 1 ml of magnetic Anti-His beads (GenScript, L00275) 2 times with 1 ml of TBS. If, however, your protein buffer does not contain Ca 2+ PBS can be used for these washes and the washes in step g. This is to remove any phosphate from the storage solution to prevent calcium-phosphate crystal formation. Omitting this step will result in large losses in later steps. g. Wash 3 more times with 1 ml of TBS + 5 mM CaCl 2 . h. Apply the product of the sortase reaction and allow 2 h rotating at 4°C for binding. i. The supernatant contains the DNA-protein hybrid, free of TEV and excess CDH23. To this supernatant, add the following and place in a new
Floatalyzer: 15 lL of 0.1 mM protein 2-LPETG-HHHHHH, and 50 lL of 14 mg/ml sortase.
j. Repeat steps b, c, d, f, g, and h. k. The supernatant contains the pure site-directedly bifunctionalized DNA-protein hybrid. l. Functionality of the nanoswitch can be assayed by gel electrophoresis as previously described in [6] .
Conclusions
We have presented detailed protocols for a reliable approach for linking proteins to DNA-oligos, while preserving protein function.
Additionally we outline methods for the incorporation of these chimeras into self-assembling nanostructures. These techniques frontload all harsh chemistries to synthetic oligos and peptides, which are more amenable to these non-physiological conditions. The use of click chemistry ensures that linkages are bioorthogonal, site directed, and efficient. The use of an evolved sortase allows for protein coupling to occur under conditions favorable for protein stability. The protocols have been designed to be resilient to changes in the protein of interest. All materials are commercially available, with the exception of the sortase (for which the plasmid is available from the Liu Lab [8] ). The built in purification schemes allow for fast and efficient purification, allowing for the immediate use of the chimeric product. When combined with a library of sortase compatible oligos and peptides, this flexible and modular approach could enable the creation of a wide range of functional nanostructures on demand. Furthermore, our approach expands the range of functional DNA-protein chimeras that can be constructed, enabling the incorporation of previously inaccessible protein machinery to generate nanostructures with previously unobtainable functionalities.
